US Stock MarketDetailed Quotes

LDTC LeddarTech

Watchlist
  • 0.528
  • -0.028-4.95%
Close Feb 28 16:00 ET
  • 0.510
  • -0.018-3.41%
Post 20:01 ET
17.35MMarket Cap-0.14P/E (TTM)

LeddarTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LeddarTech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.937M--
--2025/Q2-- / 1.394M--
--2025/Q11.207M / 911.000K--
--2024/Q43.033M / 956.000K--
--2024/Q31.423M / 818.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.937M--
--2025/Q2-- / 1.394M--
--2025/Q11.207M / 911.000K--
--2024/Q43.033M / 956.000K--
--2024/Q31.423M / 818.000K--

Unlock Free Earnings Estimates

LeddarTech Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 25 12:41 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 12 11:36 ET

  • 20-F: FY2024 Annual Report

    Dec 26, 2024 11:54 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 18, 2024 07:58 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data